{"nct_id":"NCT02822794","title":"Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Participants With Chronic Genotype 1 or 2 Hepatitis C Virus Infection Who Have Previously Failed a Direct-Acting Antiviral-Containing Regimen","status":"COMPLETED","status_verified_date":"2018-07","start_date":"2016-07-25","start_date_type":"ACTUAL","primary_completion_date":"2017-06-02","primary_completion_date_type":"ACTUAL","completion_date":"2017-08-25","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}